These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19898281)

  • 1. Ischemia is the critical determinant of revascularization benefit: an interventionalist's perspective of the COURAGE trial.
    Kereiakes DJ
    Rev Cardiovasc Med; 2009; 10 Suppl 2():S45-52. PubMed ID: 19898281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpreting the results of the COURAGE trial: a non-interventionalist perspective.
    Boden WE
    Rev Cardiovasc Med; 2009; 10 Suppl 2():S34-44. PubMed ID: 19898280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.
    Farzaneh-Far A; Phillips HR; Shaw LK; Starr AZ; Fiuzat M; O'Connor CM; Sastry A; Shaw LJ; Borges-Neto S
    JACC Cardiovasc Imaging; 2012 Jul; 5(7):715-24. PubMed ID: 22789940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One year perspective on COURAGE.
    Tommaso CL
    Catheter Cardiovasc Interv; 2008 Sep; 72(3):426-429. PubMed ID: 18727125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials.
    Stergiopoulos K; Brown DL
    Arch Intern Med; 2012 Feb; 172(4):312-9. PubMed ID: 22371919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative coronary artery revascularization and long-term outcomes following abdominal aortic vascular surgery in patients with abnormal myocardial perfusion scans: a subgroup analysis of the coronary artery revascularization prophylaxis trial.
    Garcia S; Rider JE; Moritz TE; Pierpont G; Goldman S; Larsen GC; Shunk K; Littooy F; Santilli S; Rapp J; Reda DJ; Ward HB; McFalls EO
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):134-41. PubMed ID: 20602474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of drug-eluting and bare-metal stents for stable coronary artery disease.
    Horst B; Rihal CS; Holmes DR; Bresnahan JF; Prasad A; Gau G; Lennon R; Lerman A
    JACC Cardiovasc Interv; 2009 Apr; 2(4):321-8. PubMed ID: 19463444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What can we expect in PCI in patients with chronic coronary artery disease. - Indication of PCI for angiographically significant coronary artery stenosis without objective evidence of myocardial ischemia (Con)-.
    Akasaka T
    Circ J; 2011; 75(1):211-7; discussion 210. PubMed ID: 21173503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should percutaneous revascularization for stable coronary artery disease be performed sooner or later?
    Prasad A; Gersh BJ
    JACC Cardiovasc Interv; 2008 Oct; 1(5):480-2. PubMed ID: 19463348
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of optimal medical therapy and percutaneous coronary intervention on patients with stable angina.
    Latib A; Chieffo A; Colombo A
    Nat Clin Pract Cardiovasc Med; 2009 Feb; 6(2):92-3. PubMed ID: 19065124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction.
    Lee MS; Sillano D; Latib A; Chieffo A; Zoccai GB; Bhatia R; Sheiban I; Colombo A; Tobis J
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):15-21. PubMed ID: 19089930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial.
    Garg S; Serruys PW; Silber S; Wykrzykowska J; van Geuns RJ; Richardt G; Buszman PE; Kelbæk H; van Boven AJ; Hofma SH; Linke A; Klauss V; Wijns W; Macaya C; Garot P; DiMario C; Manoharan G; Kornowski R; Ischinger T; Bartorelli A; Van Remortel E; Ronden J; Windecker S
    JACC Cardiovasc Interv; 2011 Apr; 4(4):432-41. PubMed ID: 21511223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
    Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a drug-eluting balloon first and then bare metal stent with a drug-eluting stent for treatment of de novo lesions: study protocol of a randomized controlled trial.
    Park SD; Yoon CH; Oh IY; Suh JW; Cho YS; Youn TJ; Choi DJ; Chae IH
    Trials; 2013 Feb; 14():38. PubMed ID: 23394404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.
    Onuma Y; Kukreja N; Daemen J; Garcia-Garcia HM; Gonzalo N; Cheng JM; van Twisk PH; van Domburg R; Serruys PW;
    JACC Cardiovasc Interv; 2009 Jul; 2(7):603-10. PubMed ID: 19628181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First human trial of KW39 slotted-tube stents: for percutaneous coronary intervention.
    Tanaka M; Tsuno NH; Mitsudo K; Kadota K; Tatami R; Kato M; Kato K; Nogami A; Ishikawa O; Takahashi K
    Tex Heart Inst J; 2011; 38(5):502-7. PubMed ID: 22163123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes after the percutaneous treatment of drug-eluting stent restenosis.
    Latib A; Mussardo M; Ielasi A; Tarsia G; Godino C; Al-Lamee R; Chieffo A; Airoldi F; Carlino M; Montorfano M; Colombo A
    JACC Cardiovasc Interv; 2011 Feb; 4(2):155-64. PubMed ID: 21349453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic values of C-reactive protein levels on clinical outcome after implantation of sirolimus-eluting stents in patients on hemodialysis.
    Ishii H; Toriyama T; Aoyama T; Takahashi H; Amano T; Hayashi M; Tanaka M; Kawamura Y; Yasuda Y; Yuzawa Y; Maruyama S; Matsuo S; Matsubara T; Murohara T
    Circ Cardiovasc Interv; 2009 Dec; 2(6):513-8. PubMed ID: 20031768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.